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Congenital toxoplasmosis may cause sensorineural deficit 
in up to 20% of the patients and proper treatment in the first 
year improves prognosis. In Brazil, this infection’s impact on 
hearing impairment is unknown. Aim: To evaluate hearing 
of newborns with congenital toxoplasmosis identified by the 
newborn screening service. Method: This prospective study 
analyzed children with congenital toxoplasmosis identified 
by newborn screening (IgM anti-T.gondii) in Belo Horizonte 
during 2003/2004. The presence of IgM and/or IgA in the 
first 6 months or IgG at 12 months-of age in serology was 
used as case definition. Hearing tests were carried out at the 
time of diagnosis and 12 months later, including behavioral 
audiometry, evoked otoacoustic emission and brainstem 
evoked responses audiometry. Results: Among 30.808 
screened children (97% of live births), 20 had congenital 
toxoplasmosis, 15 (75%) were asymptomatic at birth. 
Nineteen children were evaluated by hearing tests. Four had 
sensorineural impairment (21.1%). One child had other risk 
factors for hearing impairment; the other three had no other 
risk factors but toxoplasmosis. Two properly children treated 
still had hearing loss, in disagreement with current literature. 
Conclusion: Results suggest that congenital toxoplasmosis, 
common in Brazil, is a risk factor for hearing impairment and 
its impact on hearing loss deserves further studies.
Keywords: hearing loss, congenital toxoplasmosis, newborn 
screening.
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INTRODUCTION
Hearing plays an important role in the development 
of human beings. The peripheral hearing system is fully 
formed at birth, while the central auditory system takes 
two years to mature. This period corresponds to that of the 
greatest neuronal plasticity of the auditory pathway, and 
this maturing process depends on the quantity and quality 
of the external stimuli captured. Early identification and 
rehabilitation in cases of hearing loss are paramount for 
speech development (critical period and optimum period) 
1 and that of other cognitive functions at school age2. 
Hearing acuity loss (hypoacusis) evolves silently, 
especially in the first years of life, when the child still 
does not complain of hearing loss. During childhood, 
it has a world prevalence of 1/1000 live births3,4, being 
higher (2-4%) among those coming from neonatal inten-
sive care units (ICU)2,5. It is associated with genetic and 
environmental factors; however, in a significant number 
of children the etiology is unknown4,6. Among risk factors 
for hypoacusis, we have a family history of hearing deficit, 
craniofacial malformation, genetic syndrome, birth weight 
below 1000g, asphyxia, hyperbilirubinemia and mechani-
cal ventilation use5.
Hearing losses may be classified according to type 
(conductive or sensorineural), laterality, symmetry, clinical 
characteristic (syndromic or not), time of onset (congenital, 
perinatal or postnatal), hereditary (genetic or not), time 
of manifestation (prelingual, peri-lingual or post-lingual)4. 
They may also be classified as to intensity in mild, modera-
te, severe and profound. In conductive hearing loss there 
is sound conduction impairment from the outer medium 
to the cochlea; and in sensorineural hearing loss there is 
cochlea and/or cochlear nerve (central auditory pathway) 
involvement.
It is well established the association between some 
congenital infections and hearing loss. The most frequent 
infectious agents associated with hearing loss are Cytome-
galovirus (CMV)7, rubella virus3,8-10, Toxoplasma gondii and 
the herpes virus11. Recently, newborn with HIV are also 
being included in this risk group12. Children with congeni-
tal rubella have hearing deficit in up to 20% of the cases4,9 
and those infected by CMV, especially the symptomatic 
ones, may have it in up to 40% of the cases. 
Toxoplasma gondii has been associated with di-
sorders of the auditory pathways since the 1950’s13, when 
calcium deposits (similar to those found in the brains of 
children with congenital toxoplasmosis) were found in the 
spiral ligament and the cochlea14. Hearing loss has been 
reported in about 20% of the congenital toxoplasmosis 
cases, especially in untreated children or those treated 
for a very short period4,15,16. Eichenwald (1947), studied 
children who had not been treated in the first year of life 
and found hearing loss in 17% (12/70) of those children 
who had the neurologic form of the disease and in 10% 
(3/31) of those with the generalized form. Severe hearing 
loss has been almost exclusive of those cases bearing in-
tense clinical manifestations.17; however,  Wilson et al.18,19 
reported unilateral or bilateral hearing loss in 5 (26%) of 
the 19 children with subclinical infection. Other authors 
have found no association between the parasites and hy-
poacusis, when children are treated15,20, and there still are 
doubts as to the rate at which toxoplasmosis can cause 
hearing deficit13,17,21.
Considering the little information available about 
significant hearing loss in children with congenital to-
xoplasmosis, especially those with subclinical infection, 
this study aims at characterizing the hearing loss pattern 
in children with congenital toxoplasmosis, identified at 
the neonatal screening process in Belo Horizonte, Minas 
Gerais.
MATERIALS AND METHODS
From September, 2003 to October, 2004, we carried 
out a pilot project in the city of Belo Horizonte, Minas 
Gerais, for neonatal screening, using the IgM anti-T. gondii 
immune assay in dry blood, in order to assess the incidence 
of congenital toxoplasmosis in live births in the city and 
neonatal screening as a strategy for early diagnosis and 
treatment of infected children. According to 2004 data from 
SINASC/SES, the Neonatal Screening Program tested about 
97% of newborns. The criteria used to define congenital 
toxoplasmosis were those accepted by a consensus on the 
theme: positive IgM and/or IgA in the first six months, or 
persistently positive IgG at 12 months of life22.
The infected children were treated (sulfadiazine, 
pyrimethamine and folinic acid) during 12 months23, follo-
wed for 24-36 months and submitted to multiprofessional 
evaluation which consisted of pediatric, ophthalmologic 
and auditory exams. Hearing assessment was carried out 
at the time of diagnosis and 12 months afterwards, by the 
Audiology Service of the UFMG-Medical School Hospital, 
based on Behavioral Audiometry, Transient and Distortion 
Product Evoked Otoacoustic Emissions, Immitanciometry 
and Brainstem Evoked Auditory Potential (BEAP). When 
necessary and with the informed consent of the child’s 
guardian, BEAP was carried out under sedation in the 
Surgical Theater of the UFMG University Hospital (UFMG-
UH). Should doubtful results be attained, the exams were 
repeated at different time points throughout the child’s 
growth. Data collection for this study was interrupted 
when the child came to 24-36 months of life; however 
their follow up continued at the Departments of Pedia-
tric Infectology and Audiology at the UFMG-UH. Those 
children with hearing impairment were referred to the 
speech and hearing therapy and hearing aid fitting when 
that was the case. 
For speech and hearing anamneses, we used the 
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UFMG-HU Department of Audiology protocol, which in-
vestigates the variables most commonly associated with 
hearing loss4: family history of hearing loss; gestational 
problems (infections of the TORCHS group, use of abor-
tive and ototoxic drugs); delivery complications (hypoxia 
- Apgar between 0-4 in the 1st minute and 0-6 in the 5th 
minute, prematurity, low birth weight, hyperbilirubinemia, 
delivery trauma, ototoxic drugs, noise), post-natal compli-
cations (phototherapy for more than two days, incubator 
stay for more than five days, mechanical ventilation use 
for more than five days, repetition otitis, measles, bacterial 
meningitis, mumps, encephalitis, ototoxic drug use for 
more than five days, head injury, acoustic trauma, sepsis). 
We used a careful history taking as criteria to establish the 
possible etiologic associations, because it is considered the 
most efficient method6.
We used the following equipment in order to carry 
out the audiologic exams: (PA5) Interacoustics Pediatric 
Audiometer and Impedanciometer, ANSI S3.6/ISO 389 
calibration pattern. In behavioral audiometry we used 
Brazilian musical percussion instruments (agogô, sino, 
guizo, reco-reco, coco, chocalho) which were standardized 
for the evaluation. Otoacoustic emissions were captured 
using Biologic’s AuDX Plus device (protocols described on 
Table 1). BEAP was carried out with Biologic’s Navigator 
device and the EP317 software. This piece of equipment 
has two recording channels. Responses were captured by 
means of silver electrodes placed on the ear lobes (A1 and 
A2), nose (Nz) and forehead (Fz), keeping the impedance 
below 5Kohms.
The normality criteria used in the auditory potential 
analysis was proposed by Gorga et al.24, which protocol 
follows the same criteria used in the tests carried out at 
the UFMG-UH Audiology ward. 
For OAE recording, a probe was placed at the en-
trance of the external auditory meatus (EAM) which has 
a stimuli generator inside. As they hit the cochlea, these 
stimuli produce an echo - the otoemissions - which trails 
the inverse sound pathway, that is, from the inner ear 
to the middle and then to the external acoustic meatus, 
and then captured by a microphone placed in the EAM. 
If present, otoemissions hint to middle and external ear 
integrity6. Transient evoked otoacoustic emissions were 
considered present when their reproducibility was above 
70% and the response amplitude / noise ratio (R/N) was 
above that or equal to 6 dB. Distortion product evoked 
otoacoustic emissions were considered present whenever 
the R/N ratio was higher than or equal to 6 dB.
The hearing loss variables investigated were: type 
(sensorineural or conductive), intensity (mild, moderate, 
severe and profound), laterality and symmetry.
In behavioral audiometry, the response patterns 
suggesting central auditory alterations were: exacerbated 
response, response latency increase, difficulty of localiza-
tion with normal acuity, no habituation at repetitive stimuli, 
and no cochleo-eyelid reflex with normal hearing 25.
Stimuli were psychoacoustically calibrated in dBHL 
(decibels pertaining to the 0 value of the normal young 
population obtained psychoacoustically). In order to clas-
sify hearing loss levels, we considered the guidelines from 
the Bureau International D’Audiophonologie (BIAP) which 
classifies the losses in mild (minimum response levels be-
tween 21-40 dBHL), moderate (minimum response levels 
between 41-70 dBHL), severe (minimum response levels 
between 71-90 dBHL) and profound (no response to the 
stimuli employed at a maximum output of 85 dBHL)6.
Responses were considered symmetrical when the 
hearing losses were classified at the same level of impair-
ment on both sides. Asymmetry was of level 1 when the 
one side hearing loss classification was immediately adja-
cent in severity level to that of the contralateral side. The 
asymmetry was deemed of 2 levels when the classification 
of sides was not adjacent in levels of severity. 
In order to build the database, we used the Epi 
Info version 6.0 statistical package. For analysis we also 
used the StatXact software to perform Fisher’s Exact Test. 
We used the Student t test in order to compare the mean 
values and the Fisher’s Exact Test to compare gender and 
risk factor distribution. This study was approved by the 
COEP-UFMG (ETIC 157/01) and we honored the standards 
established for research with human beings, according to 
resolution 196/96 from  CONEP.
Table 1. Brainstem auditory evoked potentials recording characte-
ristics.
STIMULUS  
Transducer Supra-aural phones
Type Click
Duration 0.1 msec
Velocity 13.1/s
Polarity Rarefaction
Initial Power 85 dBHL
Ear Monoaural
AQUISITION  
Gain (amplification) 100,000
Analysis time 15 msec
High-pass filter 3000Hz
Low-pass filter 30Hz
Number of scans 2 (1024 X2)
Contralateral masking 60dB (WN)
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RESULTS
From September 2003 to October 2004, 30,808 
children (about 97% of live births) were screened in Belo 
Horizonte (BH) and 20 were identified with congenital 
toxoplasmosis, resulting in a rate of 1:1590 infected by 
live births. In relation to the time of diagnosis for these 
20 children, six (30%) had already been identified during 
prenatal care (prenatal screening program implemented 
in BH), four (20%) were identified in the neonatal pe-
riod because they had clinical manifestations suggesting 
the infection; and ten (50%) were identified by neonatal 
screening alone.
Among these 20 children identified by neonatal 
screening in BH, one was taken off the analysis because 
for having died in the neonatal period. We carried out 
behavioral auditory evaluations and Otoacoustic Emission 
tests (EOAE) in 19 children and Brainstem Evoked Auditory 
Potential - BEAP in 17. We noticed that 13 children (68.4%) 
had normal evaluation for their ages, and six had hearing 
deficit - four (21.1%) were sensorineural and two (10.5%) 
had conductive hearing loss. There was no gender wise 
difference among the three groups (p=0.99). On Table 2 
we list some of the risk factors for hypoacusis, as well as 
the frequency observed. According to Fisher’s Exact Test, 
we did not detect any difference among the three groups 
as to any of the risk factors. One child had, besides toxo-
plasmosis, two other risk factors (birth weight below 1,500g 
and were under mechanical ventilation for one month), 
and however his hearing was deemed normal. 
deviation of the birth weight of the 13 children with 
normal audiometry and those from the six children with 
hearing deficit (four classified as sensorineural and two 
as conductive). The difference among the mean values of 
birth weight associated with the two groups did not show 
statistical significance (p=0.51).
As far as neonatal signs and symptoms are con-
cerned the group without hearing alterations had three 
children with systemic manifestations (liver and spleen 
enlargement and/or petechias) and, of these, two also had 
hydrocephaly and microphthalmia. Among the children 
with hearing impairment we observed that one presented 
systemic manifestation and prematurity (Table 4). After 
more than 12 months of follow up, only one child from 
the first group and one from the second presented with 
neuropsychomotor development delay.
As to the age when the children were submitted to 
the first hearing evaluation, we observed a median value 
of 157 days, and 75% of the children were first assessed 
before 270 days. However, as we can see in Figure 1, four 
children underwent their first hearing assessment only 
at the end of their second year of life. The last hearing 
assessment was carried out at the end of their second 
year of life. The last hearing evaluation was carried out at 
the end of their second year of life (median value of 624 
days), noticing that 75% of the children underwent such 
evaluation before 710 days of life.
Among the children with sensorineural deficit (n=4), 
the hearing loss was severe and profound in one, moderate 
in one and mild in two children; and was asymmetrical in 
only one of the children with bilateral involvement (Table 
4). Only one of the children, the most severely affected 
one, had other risk factors for developing hypoacusis 
- she was under mechanical ventilation for about one 
month. This child presented clear signs and symptoms of 
congenital toxoplasmosis: prematurity, liver and spleen 
enlargement, low birth weight (1,970g) and bilateral reti-
nochoroiditis. The other three children, one with moderate 
bilateral deficit and two with mild unilateral deficit, were 
born asymptomatic and were identified only by neonatal 
screening. Two of these children were referred to wear 
hearing aids and undergo speech and hearing therapy. 
The children with conductive hearing loss were referred 
to otolaryngological evaluation. Two children, in whom it 
Table 2. Distribution of hearing loss risk factors in 19 children with 
congenital toxoplasmosis identified by the neonatal screening in 
Belo Horizonte from September 2003 to October 2004. 
Hearing loss risk factors
Normal 
hearing
n=13
Hearing loss
n=6
Conductive
n=2 
Sensori-
neural
n=4
Cranio-facial anomalies 0 1 0
Birth weight < 1,500g 1 0 0
Apgar between 0 - 4 
minutes
1 0 0
Apgar between 0 - 6 
minutes
1 0 0
Mechanical ventilation ³ 
5 days
1 1 1
In the population studied, we did not observe the 
following risk factors for hearing loss: family history, other 
TORCH intra-uterine infections, hyperbilirubinemia, use 
of ototoxic drugs, bacterial meningitis, parents who used 
drugs/alcohol, syndromes.
Table 3 shows the mean, median and standard 
Table 3. Birth weight mean, median and standard of the 19 children 
with congenital toxoplasmosis identified by neonatal screening in 
Belo Horizonte, from September 2003 to October 2004. 
Statistics
Normal hearing 
(n=13)
Hearing loss (n=6)
Mean 2,612 g 2,803 g
Median 2,590 g 2,890 g
Standard deviation 611 g 494 g
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Table 5. Results from auditory evaluation in children with congenital toxoplasmosis submitted to treatment or not, during the first year of life. 
Definitions Results of the sensorineural auditory evaluation
Hearing loss 
level
Chicago’s collaborative studya 
 Wilson et al.b 
Present investi-
gation
Chicago’s 
studya 
Wilson et 
al.bsubclínica 
 
Present in-
vestigationBERA (dB/HL)
Audiogram
(dB/HL)
Normal ≤ 20 0-20 < 25 dB ≤ 20 55 14 15
Mild > 20-40 25-40 25-50 > 20-40 0 3 (15,8%) 2 (10,5%)
Moderate > 40-60 >40 51-80 > 40-70 0 2 (10,5%) 1 (5,3%)
Severe >60 > 70-90 NE >70-90 0 0
 1 (5,3%)
Profound  >90 NE > 90 0 0
Total     55 19 19
NE=not found; BERA=cerebral auditory response; dB=decibels; HL=hearing level; NA=not assessed; Adapted from McGee et al. 15
a- Children treated in the first year of life, during 12 months15,20,28
b- Children, asymptomatic at birth and not treated or treated for a very short period, one month19
Table 4. Characteristics of children with congenital toxoplasmosis and sensorineural hearing loss according to neonatal screening in Belo 
Horizonte, from September 2003 to October 2004. 
Code / 
DN
S IG 
PN 
(g)
Apgar 
1’ / 5’
TS
I
(days)
MF VM
Clinical 
manifestations
TT
Age of hearing 
assessment (in 
months) Sensorineural 
assessment 
resultBehavioral 
and OAE
BEAP
BXX1744
29/07/03
M 34 1970 9/9 41
S
(35) 
N
S
(35) 
Premature, low 
birth weight, 
systemic 
disease, bilateral 
macular 
retinochoroiditis.
12 7, 11 11
Severe right 
side deficiency 
and profound 
to on the left
BYP1585
15/08/04
M 38 2820 NS N N N
bilateral macular 
retinochoroiditis, 
DNPM delay
3 7, 22 22
Mild left side 
retrocochlear 
deficiency
BXU1595
12/09/03 F 38 2960 8/7 N N N N
Right side 
macular 
retinochoroiditis
12 2, 18, 24
2, 21, 
26
Mild left side 
deficiency
BYA3384
22/12/03
F 38 2540 9/9 N N N N
bilateral macular 
retinochoroiditis
10, 
irregular
2 2
Bilateral 
moderate 
deficiency
DN=date of birth; S=gender; IG=gestational age in weeks; PN=birth weight; TS=blood transfusion; I=incubator > 5 days; MF= facial malfor-
mation; VM=mechanical ventilation ³ 5 days; TT=treatment time in months; N=no; S=yes; NS=does not know; EOA=otoacoustic emissions; 
PEATE=Brainstem Evoked Auditory Potential 
26
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 74 (1) JANUARY/FEBRUARY 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
was possible to provide proper treatment with anti-parasitic 
drugs, continued to present hearing deficit, contrasting 
with the findings from other authors. 
In three children without hearing impairment, who 
underwent BEAP evaluation in the first three months of life, 
and repeated the test after 18 months, we noticed hearing 
deficit in the first exam and a normal results in the second, 
suggesting a slower neural maturation in these children. 
In four children deemed normal by the BEAP at two 
years of age, in the first hearing evaluation there were not 
TEOAE, and there were DPOAE, suggesting that these may 
be more sensitive to audiologic diagnosis. 
DISCUSSION
There is a consensus about the importance of 
early hearing deficit diagnosis for a better development 
of language, cognition and child socialization. Neonatal 
hearing screening, recently mandatory as public health 
policy, will slowly reach the universe of newborns, ho-
wever, risk factors identification for hearing loss allows 
us to follow children up and to reassess them at the end 
of the first year of life, thus increasing the auditory scree-
ning sensitivity. Therefore, there is the need to implement 
effective strategies to identify risk factors associated with 
this deficiency. Among the risk factors, toxoplasmosis - a 
prevalent disease in Brazil, has not been often associated 
with hearing deficits. However, identifying children with 
sensorineural hearing loss (4/19), among those screened 
with congenital toxoplasmosis, brings up this discussion 
about the impact of this congenital infection in children 
hearing deficiencies. 
Among the 20 children identified by neonatal scre-
ening, 15 (75%) have subclinical infection and, of these, 
nine were identified by neonatal screening only.
Recent epidemiological studies16,21 aiming at associa-
ting toxoplasmosis and hypoacusis observed a higher risk 
of hearing deficit among children who were positive for T. 
gondii; however, these studies are not prospective, and for 
this reason are unable to assess other risk factors for the 
aforementioned deficit. In the present study it was possi-
ble to confirm the diagnosis of congenital toxoplasmosis, 
rule out other infectious agents associated with congenital 
infections and, during follow up of these children, to rule 
out other risk factors associated with such deficit (meninges 
infections, middle ear and external ear infections).  Among 
the four (21.1%) children identified with sensorineural he-
aring loss, one presented other risk factors for the deficit, 
two presented mild unilateral deficit with little functional 
repercussion and one presented moderate bilateral defi-
cit. The last three children were born asymptomatic and 
identified only by neonatal screening and did not show 
any other reason, except toxoplasmosis, to explain the 
findings, showing that such parasitosis, even in the absence 
of other clinical manifestations, must be considered in the 
assessment of children with hearing loss. 
Longitudinal studies with newborns followed up 
during long periods pointed to a high index of abstention 
from the mothers at scheduled return visits2. In four cases 
of our study, the medical visits did not occur at the required 
regular intervals; however, all the children came for at least 
one hearing evaluation, and this may be associated to the 
fact that the guardians knew that the child had some risk 
factor for hearing loss. The delay seen in four children to 
undergo the first hearing assessment may be attributed to 
the work or maternal disease, mother’s lack of interest, 
difficulty in transporting the child to the audiology ward, 
difficulty in handling the child for exam purposes, and 
others. Efforts must be made in order to identify early on 
the prevalent congenital infections, including toxoplasmo-
sis, facilitating early access to audiology services. 
Long standing treatments (one year) for congenital 
toxoplasmosis have been associated to better children 
prognosis by some authors15,20. Among the four children 
in the present study, one received antiparasitic drugs for 
three months only (this mother, a teenager, was not inte-
rested in her child’s problem) and the other was irregularly 
treated for 10 months (did not regularly come for visits at 
the ward); the most affected child and the other one with 
unilateral hearing loss were treated during 12 months.
Table 5 shows comparisons of three studies which 
encompassed hearing evaluation in children with con-
genital toxoplasmosis. The Chicago Study 15,20 evaluated 
children treated with the classical antiparasitic drugs for 12 
Figure 1. Age, in days, after the firs auditory evaluation in 19 children 
with congenital toxoplasmosis, identified by neonatal screening.
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months; Wilson et al’s study.19 describes the findings from 
19 children with subclinical infection who did not receive 
specific treatment, or received it for a very short time; and 
the present study, in which among the 19 children treated 
three were not properly treated (little time) and, of these, 
two had hearing deficits.
The results observed in this study are similar to 
those found by Wilson et al.19 Studies with larger sam-
ples, submitted to long stand treatment (12 months), did 
not identify the presence of hypoacusis, concluding for a 
better prognosis of the treated children20. In the present 
investigation, among the 16 children properly treated, for 
long time and regularly, two presented hearing deficit, 
but only one had an important functional loss. This child 
was born severely affected by the infection and presented 
other risk factors for hearing loss besides parasitosis (low 
birth weight and long term use of assisted ventilation), and 
developed hearing and ocular sequelae despite treatment. 
Hearing loss occurring because of assisted ventilation 
for more than five days can be associated with the noise 
produced by the breathing devices, mechanical ventilation 
duration and involved pulmonary pathologies5. As far as 
birth weight is concerned, although such child presented 
with low birth weight, hypoacusis risk is greater in new-
born with birth weight below 1,500g, although we can 
not disregard perinatal care situations5. Therefore, in this 
child we can not relate hearing loss with toxoplasmosis, 
although the clinical picture she had characterizes a severe 
disease stage. 
As to hearing loss intensity and its functional me-
aning, studies have assessed the importance of unilateral 
or bilateral mild hearing losses for the development of 
children and have suggested that these losses may affect 
many domains such as language skills, speech perception, 
auditory functional skills, academic performance, socio-
emotional development, motor skills including early mo-
vements and coordination26. In general, these losses have 
been identified later on, between 5-6 years of age2 and 
the knowledge regarding a risk factor for the loss, such 
as toxoplasmosis, may help speed up the access of such 
children to an audiology service or speech and hearing 
therapy. 
A historical cohort study carried out at the Pediatric 
Infectology Service of the UFMG-UH, evaluating BEAP 
audiometry in 49 children with congenital toxoplasmosis, 
most of them with early manifestations of the infection, and 
followed for 10.3 years in average, showed alterations in 
five cases (10.2%) and no association between treatment 
type in the first year of life and hearing deficit27. In the 
present study, proper treatment of two of these children 
with hearing loss did not help avoid the loss, and this is 
different from the results attained by McGee et al.15 and 
McLeod et al.20 who reported hearing normality in treated 
children, even when they had neurologic and ocular in-
volvement. The follow up of these children may provide 
new data to clarify these issues. 
CONCLUSION
The results observed in the present study suggest 
that congenital toxoplasmosis, common in Brazil, is a risk 
factor for hearing loss; and studies assessing the impact 
of the subclinical infection on hearing loss are imperati-
ve. Facing the possibility of implementing a prenatal or 
neonatal screening program for congenital toxoplasmosis, 
its planning must include early auditory evaluation for 
identified cases. Toxoplasmosis, especially when asymp-
tomatic at birth, may be included among the “Unknown 
causes” of hearing loss and all effort should be put up in 
order to identify the children at risk and allow for early 
diagnosis and treatment, which have been associated with 
a significantly better prognosis20.
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